The Department of Health has completed its triennial reviews of the British Pharmacopoeia Commission (BPC), the Commission on Human Medicines (CHM), the Administration of Radioactive Substances Advisory Committee (ARSAC), and the Independent Reconfiguration Panel (IRP), and is today publishing the associated review reports.
The four reviews, which each commenced on 30 October 2014, consulted with a wide range of stakeholders. Their key conclusions were that all these bodies perform necessary functions and should continue to operate as advisory non-department public bodies. The review reports each contain several further recommendations, intended to further improve performance, governance and efficiency.
Copies of the four reports can be found at: http://www.parliament.uk/business/publications/written-questions-answers-statements/written-statement/Commons/2015-03-26/HCWS500/